Shares of Qiagen NV (NASDAQ:QGEN) gapped up before the market opened on Monday . The stock had previously closed at $27.12, but opened at $27.22. Qiagen NV shares last traded at $27.50, with a volume of 270,877 shares traded.

QGEN has been the subject of a number of analyst reports. DZ Bank AG reaffirmed a “buy” rating on shares of Qiagen NV in a report on Friday, July 29th. Commerzbank AG reaffirmed a “buy” rating on shares of Qiagen NV in a report on Friday, July 29th. Morgan Stanley reissued a “buy” rating on shares of Qiagen NV in a report on Wednesday, June 8th. Deutsche Bank AG reissued a “buy” rating on shares of Qiagen NV in a report on Monday, June 6th. Finally, HSBC raised shares of Qiagen NV from a “hold” rating to a “buy” rating in a report on Monday, August 1st. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $25.73.

The company has a 50 day moving average of $23.77 and a 200 day moving average of $22.40. The firm has a market cap of $6.45 billion and a PE ratio of 55.10.

Qiagen NV (NASDAQ:QGEN) last released its quarterly earnings results on Thursday, July 28th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.23 by $0.01. The business had revenue of $334.40 million for the quarter, compared to the consensus estimate of $326.73 million. During the same period in the previous year, the business posted $0.26 EPS. Qiagen NV’s revenue was up 4.7% on a year-over-year basis. Equities analysts anticipate that Qiagen NV will post $1.09 earnings per share for the current fiscal year.

An institutional investor recently raised its position in Qiagen NV stock. Platinum Investment Management Ltd. raised its stake in shares of Qiagen NV (NASDAQ:QGEN) by 16.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,471,848 shares of the company’s stock after buying an additional 209,100 shares during the period. Platinum Investment Management Ltd. owned 0.63% of Qiagen NV worth $40,696,000 as of its most recent SEC filing.

QIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.